Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature

Forensic Science International

Volumn 240, Issue , 2014, Pages 1-8

  Ruiz Colón, Kazandra ^a   Chavez Arias, Carlos ^a   Díaz Alcalá, José Eric ^b   Martínez, María A ^c  

^a Institute of Forensic Sciences of Puerto Rico   (Puerto Rico)

^b Diagnostic Radiology Section   (Puerto Rico)

^c Ministerio de Justicia   (Spain)

Author keywords

Adulterant; Cocaine; Heroin; Speedball; Xylazine

Indexed keywords

ACTIVATED CARBON; ATROPINE; COCAINE; DIAMORPHINE; ENOXAPARIN; ETOMIDATE; FLUCLOXACILLIN; INSULIN; LAXATIVE; LIDOCAINE; LORAZEPAM; METOCLOPRAMIDE; METOPROLOL SUCCINATE; MIDAZOLAM; NALOXONE; ORCIPRENALINE; OXYGEN; PROPOFOL; RANITIDINE; RECREATIONAL DRUG; THIAMINE; VECURONIUM; XYLAZINE; HYPNOTIC SEDATIVE AGENT;

BLADDER CATHETERIZATION; BRADYCARDIA; CENTRAL NERVOUS SYSTEM DEPRESSION; CHRONIC DRUG ADMINISTRATION; DETERIORATION; DRUG ABUSE; DRUG INTOXICATION; DRUG MISUSE; DRUG SELF ADMINISTRATION; ENDOTRACHEAL INTUBATION; FATALITY; FLUID THERAPY; HOMICIDE; HUMAN; HYPOTENSION; INSOMNIA; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SELF INJECTION; SKIN ULCER; STOMACH LAVAGE; SUICIDE ATTEMPT; ADDICTION; CHEMICAL STRUCTURE; CHEMICALLY INDUCED; CHEMISTRY; CHROMATOGRAPHY; COMPLICATION; DRUG CONTAMINATION; FORENSIC TOXICOLOGY; HYPERGLYCEMIA; MIOSIS; RESPIRATORY FAILURE;

BRADYCARDIA; CHROMATOGRAPHY; DRUG CONTAMINATION; FORENSIC TOXICOLOGY; HUMANS; HYPERGLYCEMIA; HYPNOTICS AND SEDATIVES; HYPOTENSION; MIOSIS; MOLECULAR STRUCTURE; RESPIRATORY INSUFFICIENCY; SUBSTANCE-RELATED DISORDERS; XYLAZINE;

EID: 84901200350     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2014.03.015     Document Type: Review

References (52)

1. Stillwell M.E. A reported case involving impaired driving following self-administration of xylazine. Forensic Sci. Int. 2003, 134(1):25-28.
2. U.S. Food and Drug Administration, Animal & Veterinary, Animal Drugs@FDA . http://www.accessdata.fda.gov/scripts/animaldrugsatfda/.
3. Hoffmann U., Meister C.M., Golle K., Zschiesche M. Severe intoxication with the veterinary tranquilizer xylazine in humans. J. Anal. Toxicol. 2001, 25:245-249.
4. Vélez L.I., Shepherd G., Mills L.D., Rivera W. Systemic toxicity after an ocular exposure to xylazine hydrochloride. J. Emerg. Med. 2006, 30(4):407-410.
5. Paddleford R.R., Harvey R.C. Alpha-2 agonists and antagonists. Vet. Clin. North Am. Small Anim. Pract. 1999, 29:737-745.
6. Spyridaki M.H., Lyris E., Georgoulakis I., Kouretas D., Konstantinidou M., Georgakopoulos C.G. Determination of xylazine and its metabolites by GC-MS in equine urine for doping analysis. J. Pharm. Biomed. Anal. 2004, 35(1):107-116.
7. Greene S.A., Thurmon J.C. Xylazine-a review of its pharmacology and use in veterinary medicine. J. Vet. Pharmacol. Ther. 1988, 11(4):295-313.
8. Gallanosa A.G., Spyker D.A., Shipe J.R., Morris D.D. Human xylazine overdose: a comparative review of clonidine. Clin. Toxicol. 1981, 18(6):663-678.
9. Garcia-Villar R., Toutain P.L., Alvinerie M., Ruckebusch Y. The pharmacokinetics of xylazine hydrochloride: an interspecific study. J. Vet. Pharmacol. Ther. 1981, 4(2):87-92.
10. Carruthers S.G., Nelson M., Wexler H.R., Stiller C.R. Xylazine hydrochloridine (Rompun) overdose in man. Clin. Toxicol. 1979, 15(3):281-285.
11. Putter J., Sagner G. Chemical studies to detect residues of xylazine hydrochloride. Vet. Med. Rev. 1973, 73:145-159.
12. Mutlib A.E., Chui Y.C., Young L.M., Abbott F.S. Characterization of metabolites of xylazine produced in vivo and in vitro by LC/MS/MS and by GC/MS. Drug Metab. Dispos. 1992, 20(6):840-848.
13. Lavoie D.S., Pailleux F., Vachon P., Beaudry F. Characterization of xylazine metabolism in rat liver microsomes using liquid chromatography-hybrid triple quadrupole-linear ion trap-mass spectrometry. Biomed. Chromatogr. 2013, 27(7):882-888.
14. Meyer G.M., Maurer H.H. Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC-MS, LC-MSn, and LC-HR-MSn. Anal. Bioanal. Chem. 2013, 405(30):9779-9789.
15. Torruella R.A. Xylazine (veterinary sedative) use in Puerto Rico. Subst. Abuse Treat Prev. Policy 2011, 6:7.
16. Ruiz-Colón K., Martínez M.A., Silva-Torres L.A., Chavez-Arias C., Meléndez-Negrón M., Conte-Miller M.S., Bloom-Oquendo J. Simultaneous determination of xylazine, free morphine, codeine, 6-acetylmorphine, cocaine and benzoylecgonine in postmortem blood by UPLC-MS-MS. J. Anal. Toxicol. 2012, 36(5):319-326.
17. Rodríguez N., Vargas Vidot J., Panelli J., Colón H., Ritchie B., Yamamura Y. GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles. Drug Alcohol Depend. 2008, 96(3):290-293.
18. Darke S., Zador D. Fatal heroin 'overdose': a review. Addiction 1996, 91(12):1765-1772.
19. Hosztafi S. Heroin, part III: the pharmacology of heroin. Acta Pharm. Hung. 2003, 73(3):197-205.
20. Dixon P. Managing acute heroin overdose. Emerg. Nurse 2007, 15(2):30-35.
21. Esse K., Fossati-Bellani M., Traylor A., Martin-Schild S. Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard. Brain Behav. 2011, 1(1):44-54.
22. Demuro J.P., Mongelli M.N., Hanna A.F. Use of dexmedetomidine to facilitate non-invasive ventilation. Int. J. Crit. Illn. Inj. Sci. 2013, 3(4):274-275.
23. Spoerke D.G., Hall A.H., Grimes M.J., Honea B.N., Rumack B.H. Human overdose with the veterinary tranquilizer xylazine. Am. J. Emerg. Med. 1986, 4(3):222-224.
24. Lewis S., O'Callaghan C.L.P., Toghill P.J. Clinical curio: self-medication with xylazine. Br. Med. J. 1983, 287:1369.
25. Haigh J.C. Misuse of xylazine. Can. Vet. J. 1988, 29(10):782-784.
26. Samanta A., Roffe C., Woods K.L. Accidental self administration of xylazine in a veterinary nurse. Postgrad. Med. J. 1990, 66:244-245.
27. Capraro A.J., Wiley J.F., Tucker J.R. Severe intoxication from xylazine inhalation. Pediatr. Emerg. Care 2001, 17(6):447-448.
28. Elejalde J.I., Louis C.J., Elcuaz R., Pinillos M.A. Drug abuse with inhalated xylazine. Eur. J. Emerg. Med. 2003, 10(3):252-253.
29. Arican F.O., Okan T., Badak O., Guneri S. An unusual presentation from xylazine-ketamine. Vet. Hum. Toxicol. 2004, 46(6):324-325.
30. Barroso M., Gallardo E., Margalho C., Devesa N., Pimentel J., Vieira D.N. Solid-phase extraction and gas chromatographic-mass spectrometric determination of the veterinary drug xylazine in human blood. J. Anal. Toxicol. 2007, 31(3):165-169.
31. Liu C.M., Chiu M.J., Fang C.C., Chen W.J. Xylazine abuse: a rare cause of syncope. Clin. Toxicol. (Phila) 2007, 45(3):309-311.
32. Meyer G.M., Meyer M.R., Mischo B., Schofer O., Maurer H.H. Case report of accidental poisoning with the tranquilizer xylazine and the anesthetic ketamine confirmed by qualitative and quantitative toxicological analysis using GC-MS and LC-MS. Drug Test. Anal. 2013, 5(9-10):785-789.
33. Wong S.C., Curtis J.A., Wingert W.E. Concurrent detection of heroin, fentanyl, and xylazine in seven drug-related deaths reported from the Philadelphia Medical Examiner's Office. J. Forensic Sci. 2008, 53(2):495-498.
34. Chavez C., Sanabria D., Ruiz K. Nine xylazine related deaths in Puerto Rico, oral presentation (K44). Forensic Toxicology Proceedings 2002-2011 2009, 77 pp. American Academy of Forensic Sciences.
35. Poklis A., Mackell M.A., Case M. Xylazine in human tissues and fluids in a case of fatal drug abuse. J. Anal. Toxicol. 1985, 9:234-236.
36. Briellmann Th.A., Rickli R., Jenny C. A fatal intoxication with xylazine. TIAFT Bull. Case Notes 1994, 24:28-30.
37. Mittleman R.E., Hearn W.L., Hime G.W. Xylazine toxicity-literature review and report of two cases. J. Forensic Sci. 1998, 43:400-402.
38. Moore K.A., Ripple M.G., Sakinedzad S., Levine B., Fowler D.R. Tissue distribution of xylazine in a suicide by hanging. J. Anal. Toxicol. 2003, 27(2):110-112.
39. Reyes J.C., Negrón J.L., Colón H.M., Padilla A.M., Millán M.Y., Matos T.D., Robles R.R. The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico. J. Urban Health 2012, 89(3):519-526.
40. Baselt R.C. Disposition of Toxic Drugs and Chemicals in Man 2008, Biomedical Publication, California, 730 pp. 8th ed.
41. Bruton L., Parker K., Blumenthal D., Buxton L. Goodman and Gilmans's, Manual of Pharmacology and Therapeutics 2008, McGraw-Hill Companies, United States of America, 394 pp.
42. Kreek M.J., Bart G., Lilly C., LaForge K.S., Nielsen D.A. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol. Rev. 2005, 57(1):1-26.
43. Fitzgerald P.J. Elevated norepinephrine may be a unifying etiological factor in the abuse of a broad range of substances: alcohol, nicotine, Marijuana, Heroin, Cocaine, and Caffeine. Subst. Abuse 2013, 13(7):171-183.
44. Huska G.R. Xylazine-morphine sequence to obtain analgesia in the horse and dog. Can. Vet. J. 1977, 18(11):317.
45. Bennett R.C., Steffey E.P., Kollias-Baker C., Sams R. Influence of morphine sulfate on the halothane sparing effect of xylazine hydrochloride in horses. Am. J. Vet. Res. 2004, 65(4):519-526.
46. Keegan R.D., Greene S.A., Weil A.B. Cardiovascular effects of epidurally administered morphine and a xylazine-morphine combination in isoflurane-anesthetized dogs. Am. J. Vet. Res. 1995, 56(4):496-500.
47. Levine B. Principles of Forensic Toxicology 2010, 247-248. District of Columbia, Washington, 60 pp. 3rd ed.
48. Leri F., Bruneau J., Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction 2003, 98(1):7-22.
49. Lindsey W.T., Stewart D., Childress D. Drug interactions between common illicit drugs and prescription therapies. Am. J. Drug Alcohol Abuse 2012, 38(4):334-343.
50. Leonhardt J.H., Freire A.C. Effect of cocaine on xylazine analgesic activity. Braz. J. Med. Biol. Res. 1988, 21(1):103-105.
51. Rhodes T., Briggs D., Kimber J., Jones S., Holloway G. Crack-heroin speedball injection and its implications for vein care: qualitative study. Addiction 2007, 102(11):1782-1790.
52. Ruiz K., Chavez C., Meléndez M. Prevalence of xylazine in postmortem cases related to heroin and/or cocaine intoxication. American College of Medical Toxicology Annual Scientific Meeting in San Juan, Puerto Rico 2013.